LEVAQUIN Safety Questions, LEVAQUIN Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about LEVAQUIN. Our extensive database of LEVAQUIN adverse events and LEVAQUIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about LEVAQUIN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




LEVAQUIN Safety Reports

Total LEVAQUIN reports: 866.
LEVAQUIN FDA safety alerts: No.
Reported deaths: 33    Reported hospitalizations: 178.
Take LEVAQUIN Side Effects Survey or Share Your LEVAQUIN Story. LEVAQUIN Usage.

Showing 1-75 of 866 Next >

Physician from UNITED STATES reported LEVAQUIN problem on Feb 23, 2007. Male patient, 64 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hepatitis c, liver injury. LEVAQUIN dosage: unknown. During the same period patient was treated with ATENOLOL, DOXAZOCIN, NEXIUM, INSULIN, LISINOPRIL, TAMSULOSIN. Patient recovered.

LEVAQUIN problem was reported by a Pharmacist from UNITED STATES on Feb 16, 2007. Female patient, weighting 233.0 lb, was diagnosed with cellulitis, diabetes mellitus, hypertension, neuropathy, blood cholesterol and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: blood glucose fluctuation, unresponsive to stimuli. LEVAQUIN dosage: unknown. During the same period patient was treated with NOVOLIN, METFORMIN, LISINOPRIL, AMITRIPTYLINE, CLONIDINE, ESTROGENS SOL, GEMFIBROZIL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Feb 26, 2007. Female patient, 53 years of age, weighting 170.0 lb, was diagnosed with arthropod bite and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, insomnia, musculoskeletal pain, pain in extremity. LEVAQUIN dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2007. Female patient, 52 years of age, weighting 125.0 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: abdominal distension, burning sensation, chest discomfort, chest pain, chills, eructation, feeling abnormal, flatulence, headache. LEVAQUIN dosage: 500MG 1 DAILY FOR 10 DAY PO. Patient recovered.

Pharmacist from UNITED STATES reported LEVAQUIN problem on Feb 28, 2007. Male patient, 73 years of age, weighting 132.0 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: encephalitis herpes, grand mal convulsion, hallucination. LEVAQUIN dosage: 750MG DAILY PO. During the same period patient was treated with FOSAMAX, CALCIUM, VITAMIN D, ADVAIR DISKUS, SPIRIVA, PREDNISONE. Patient was hospitalized. Patient recovered.

LEVAQUIN problem was reported by a Pharmacist from UNITED STATES on Sept 05, 2006. Female patient, 29 years of age, weighting 222.9 lb, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. LEVAQUIN dosage: 500 MG, IN 1 DAY, INTRAVENOUS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Jan 05, 2006. Female patient, 34 years of age, weighting 190.0 lb, was diagnosed with pneumonia and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, dizziness, oedema, tendon disorder, urticaria. LEVAQUIN dosage: unknown. Patient recovered.

LEVAQUIN problem was reported by a Health Professional from UNITED STATES on May 11, 2006. Male patient, 62 years of age, weighting 200.0 lb, was diagnosed with bacterial infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: renal failure, stevens-johnson syndrome. LEVAQUIN dosage: 250 MG, 1 IN 1 DAY, INTRAVENOUS. During the same period patient was treated with CEPHALEXIN, ALLOPURINOL, ZOSYN, CIPROFLOXACIN, CLARITIN, PROTONIX, ZOLOFT. Patient died on 11/01/2003.

Pharmacist from UNITED STATES reported LEVAQUIN problem on Feb 16, 2006. Male patient, 83 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: convulsion. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, INTRAVENOUS. Patient recovered.

LEVAQUIN problem was reported by a Pharmacist from UNITED STATES on Apr 11, 2006. Female patient, 67 years of age, weighting 167.0 lb, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: burning sensation, dyspnoea. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, INTRAVENOUS. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Oct 18, 2005. Female patient, 78 years of age, was diagnosed with urinary tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, weight decreased. LEVAQUIN dosage: unknown. During the same period patient was treated with PROCARDIA. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Dec 16, 2005. Male patient, 78 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: renal failure acute. LEVAQUIN dosage: unknown. Patient recovered.

Pharmacist from UNITED STATES reported LEVAQUIN problem on Nov 02, 2005. Male patient, 91 years of age, weighting 199.0 lb, was diagnosed with urinary tract infection, diabetes mellitus and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, hypoglycaemia. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY. During the same period patient was treated with GLYBURIDE. Patient was hospitalized. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 14, 2005. Female patient, 84 years of age, was diagnosed with pneumonia and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hallucination, irritability, paranoia, rash erythematous. LEVAQUIN dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Feb 20, 2007. Male patient, 47 years of age, was diagnosed with prostatitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: change of bowel habit, dysuria, hypoaesthesia, sensory disturbance. LEVAQUIN dosage: unknown. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 21, 2007. Female patient, weighting 135.0 lb, was diagnosed with pneumonia and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hallucination. LEVAQUIN dosage: unknown. Patient recovered.

Consumer or non-health professional from reported LEVAQUIN problem on Feb 20, 2007. Female patient was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hepatitis fulminant. LEVAQUIN dosage: DOSE: 500 MG. During the same period patient was treated with FLAGYL, ASPIRIN, FERROUS GLUCONATE, METFORMIN, PREVACID, TAMIFLU. Patient died.

LEVAQUIN problem was reported by a Health Professional from UNITED STATES on Feb 20, 2007. Male patient, weighting 140.0 lb, was diagnosed with prostatic operation and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon rupture, ventricular fibrillation. LEVAQUIN dosage: unknown. During the same period patient was treated with LOTREL, COREG, BICARBONATE, LASIX, FERROUS SULPHATE. Patient died on 02/22/2006.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Feb 22, 2007. Male patient, weighting 190.0 lb, was diagnosed with cystitis, heart rate increased and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: implantable defibrillator malfunction. LEVAQUIN dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, BETEPHASE. Patient was hospitalized. Patient recovered.

LEVAQUIN problem was reported by a Pharmacist from UNITED STATES on Mar 02, 2007. Male patient, 91 years of age, weighting 181.8 lb, was diagnosed with diabetic foot, diabetes mellitus and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased. LEVAQUIN dosage: 500 MG PO DAILY. During the same period patient was treated with GLYBURIDE. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Mar 02, 2007. Male patient, weighting 182.0 lb, was diagnosed with infection prophylaxis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, pain in extremity, skin warm, tenderness. LEVAQUIN dosage: 400 MG A DAY. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2007. Female patient, 35 years of age, weighting 121.0 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: anxiety, dizziness, panic attack. LEVAQUIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Feb 27, 2007. Male patient, weighting 235.0 lb, was diagnosed with chronic sinusitis, blood cholesterol, hypertension and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: gastrooesophageal reflux disease, hiatus hernia. LEVAQUIN dosage: unknown. During the same period patient was treated with TRICOR, ALTACE, ASPIRIN. Patient was hospitalized. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on July 07, 2006. Female patient, 58 years of age, weighting 160.0 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: anorexia, depression, disturbance in attention, dyspepsia, insomnia, nausea, weight decreased. LEVAQUIN dosage: unknown. During the same period patient was treated with HORMONE REPLACEMENT, ATENOLOL, ADALAT, MAXIDE, LIPITOR, DRIXORAL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Apr 13, 2006. Male patient, 50 years of age, was diagnosed with infected cyst and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendonitis. LEVAQUIN dosage: unknown. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on May 08, 2006. Female patient, 26 years of age, was diagnosed with pelvic inflammatory disease and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: pancytopenia. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Apr 18, 2006. Female patient, 41 years of age, was diagnosed with infection prophylaxis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: anxiety, insomnia, panic attack, tremor. LEVAQUIN dosage: unknown. Patient recovered.

LEVAQUIN problem was reported by a Health Professional from UNITED STATES on Apr 06, 2006. Male patient, 71 years of age, weighting 137.3 lb, was diagnosed with urinary tract infection, intestinal functional disorder and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: renal failure. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with INVESTIGATIONAL PRODUCT. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Apr 04, 2006. Female patient, 52 years of age, was diagnosed with cystitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: anaphylactoid reaction. LEVAQUIN dosage: 750 MG, 1 IN 1 DAY, ORAL. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 04, 2006. Female patient, 62 years of age, was diagnosed with bronchitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, myalgia, tendon rupture. LEVAQUIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Mar 29, 2006. Female patient, 65 years of age, weighting 181.0 lb, was diagnosed with pyrexia, urinary tract infection, diabetes mellitus and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia, hypoglycaemia, vulvovaginal mycotic infection. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with GLIPIZIDE. Patient recovered.

LEVAQUIN problem was reported by a Health Professional from UNITED STATES on Mar 20, 2006. Female patient, 55 years of age, weighting 195.0 lb, was diagnosed with lower respiratory tract infection, diabetes mellitus non-insulin-dependent and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, pain in extremity. LEVAQUIN dosage: unknown. During the same period patient was treated with BYETTA, GLYBURIDE. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on July 10, 2006. Female patient, 61 years of age, weighting 124.0 lb, was diagnosed with chronic obstructive pulmonary disease, respiratory tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon rupture, tendonitis. LEVAQUIN dosage: unknown. During the same period patient was treated with PREDNISONE. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 31, 2006. Female patient, 23 years of age, weighting 99.00 lb, was diagnosed with cystitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, musculoskeletal stiffness, pain in extremity. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with BIRTH CONTROL SHOT. Patient recovered.

Pharmacist from UNITED STATES reported LEVAQUIN problem on Apr 18, 2006. Male patient, 56 years of age, weighting 242.0 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with BETAPACE. Patient was hospitalized. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Mar 27, 2006. Male patient, 14 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: suicidal ideation. LEVAQUIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Mar 27, 2006. Female patient, 81 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: suicidal ideation. LEVAQUIN dosage: unknown. Patient was hospitalized. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Aug 01, 2006. Female patient, 65 years of age, weighting 135.0 lb, was diagnosed with sinusitis, hypertension and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, arthralgia, blood sodium decreased, convulsion, diarrhoea, face oedema, feeling abnormal, hypomagnesaemia, pharyngeal oedema. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with BENICAR, MUCINEX, LOPRESSOR, EVISTA, ZOCOR, TRIAVIL, CENTRUM SILVER, CALCIUM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Mar 16, 2006. Female patient, 48 years of age, weighting 300.0 lb, was diagnosed with upper respiratory tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: anxiety, depression, panic attack, suicidal ideation. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY. During the same period patient was treated with LAVOXYL. Patient recovered.

LEVAQUIN problem was reported by a Pharmacist from UNITED STATES on Mar 17, 2006. Female patient was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: blood sodium decreased. LEVAQUIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Apr 10, 2006. Female patient, 61 years of age, weighting 177.0 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: vasculitis. LEVAQUIN dosage: 750 MG. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2006. Female patient, 63 years of age, weighting 180.0 lb, was diagnosed with prophylaxis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: asthenia, blood glucose abnormal, dizziness, fatigue, paraesthesia, urinary tract infection, vision blurred. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LEVAQUIN problem on Mar 21, 2006. Female patient, weighting 145.0 lb, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: asthenia, blood glucose decreased, hypoaesthesia. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 23, 2006. Female patient, 46 years of age, weighting 145.0 lb, was diagnosed with pleurisy, pneumonia and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, constipation, erythema, heart rate increased, muscle spasms, pain in extremity. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Mar 21, 2006. Female patient, 81 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. LEVAQUIN dosage: unknown. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Mar 22, 2006. Female patient was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. LEVAQUIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Mar 27, 2006. Female patient was diagnosed with postoperative care and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, tendon disorder, tendonitis. LEVAQUIN dosage: 500 MG, 2 IN 1 DAY. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on May 11, 2006. Female patient, 27 years of age, weighting 158.0 lb, was diagnosed with bronchitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient recovered.

Health Professional from UNITED STATES reported LEVAQUIN problem on Sept 08, 2006. Male patient, 65 years of age, was diagnosed with kidney infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, headache, nightmare, oxygen saturation decreased, tendon disorder. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with LISINOPRIL, ELMIRON, AMBIEN, ROCEPHIN. Patient died.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Apr 11, 2006. Male patient, 62 years of age, was diagnosed with prophylaxis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: convulsion, escherichia bacteraemia, pathogen resistance, pyrexia. LEVAQUIN dosage: 500 MG. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Apr 28, 2006. Male patient, 42 years of age, was diagnosed with urinary tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: chest pain, hyperhidrosis, nausea. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient was hospitalized. Patient recovered.

LEVAQUIN problem was reported by a Pharmacist from UNITED STATES on Mar 03, 2006. Female patient, 24 years of age, was diagnosed with prophylaxis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY. During the same period patient was treated with ASACOL, FLAGYL, PREDNISONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Mar 03, 2006. Female patient, 65 years of age, was diagnosed with bronchitis, sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. LEVAQUIN dosage: 750 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with CRANTEX LA, DIOVAN HCT, PREMARIN. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Apr 04, 2006. Female patient, 21 years of age, weighting 140.0 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: depressed mood, suicidal ideation. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on Aug 22, 2006. Female patient, 62 years of age, weighting 150.0 lb, was diagnosed with upper respiratory tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon disorder. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Mar 13, 2006. Female patient, 70 years of age, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LEVAQUIN problem on Apr 28, 2006. Female patient, 41 years of age, was diagnosed with infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: prothrombin time prolonged. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with COUMADIN, DEPAKOTE SPRINKLES, MIRALEX, PREVACID, ROBINUL, SYNTHROID, LAMICTAL. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 19, 2006. Female patient, 33 years of age, weighting 290.0 lb, was diagnosed with bronchitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, osteoarthritis. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Aug 15, 2006. Male patient, 73 years of age, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon rupture. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with TESLLON. Patient recovered.

LEVAQUIN problem was reported by a Pharmacist from UNITED STATES on July 19, 2006. Male patient, 63 years of age, weighting 217.0 lb, was diagnosed with pneumonia and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: convulsion. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY. During the same period patient was treated with THEOPHYLLINE, PLAVIX, LIPITOR, ASPIRIN, CLARITIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LEVAQUIN problem on July 21, 2006. Male patient, weighting 300.0 lb, was diagnosed with skin infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: electrocardiogram qt prolonged. LEVAQUIN dosage: 750 MG, 1 IN 1 DAY, ORAL. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2006. Female patient, 64 years of age, weighting 160.0 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: rotator cuff syndrome. LEVAQUIN dosage: 750 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with RESTORIL, SYNTHROID, SINGULAR, CARDIZEM, NEXIUM, ASPIRIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LEVAQUIN problem on July 14, 2006. Female patient, 38 years of age, weighting 208.0 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, erythema, hypoaesthesia oral, paraesthesia oral, swelling face. LEVAQUIN dosage: 750 MG, 1 IN 1 DAY, ORAL. Patient recovered.

LEVAQUIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2006. Female patient, 41 years of age, weighting 132.0 lb, was diagnosed with upper respiratory tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: anxiety, arthralgia, back pain, burning sensation, candidiasis, confusional state, depression, eye swelling, hallucination. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with ESTROSTEP, FIORCET, LORAZEPAM. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on July 14, 2006. Female patient, 36 years of age, was diagnosed with bronchitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: dysphagia, eye swelling, rash. LEVAQUIN dosage: unknown. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Dec 21, 2005. Female patient, 61 years of age, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: tendon rupture. LEVAQUIN dosage: 500 MG. During the same period patient was treated with ADVAIR, ASTELIN, ALBUTEROL, NASACORT, CLARINEX, PROBENECID, MAXIDE. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Mar 10, 2006. Female patient, 57 years of age, weighting 164.0 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: convulsion. LEVAQUIN dosage: 750 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with DILANTIN, PRIMADONE. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Nov 22, 2005. Female patient, 81 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: clostridial infection. LEVAQUIN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Nov 22, 2005. Female patient, 45 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: clostridial infection. LEVAQUIN dosage: unknown. Patient recovered.

LEVAQUIN problem was reported by a Physician from UNITED STATES on Nov 22, 2005. Female patient was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage. LEVAQUIN dosage: 750 MG, 1 IN 1 DAY, ORAL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Dec 21, 2005. Male patient, 28 years of age, weighting 180.0 lb, was diagnosed with sinusitis and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, fatigue, myalgia, neuropathy. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. During the same period patient was treated with CIPROFLOXACIN. Patient recovered.

LEVAQUIN problem was reported by a Pharmacist from UNITED STATES on Dec 27, 2005. Male patient was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: eosinophilia. LEVAQUIN dosage: 500 MG, 1 IN 1 DAY, ORAL. Patient recovered.

Physician from UNITED STATES reported LEVAQUIN problem on Nov 16, 2005. Female patient, 50 years of age, was diagnosed with respiratory tract infection and was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: polyneuropathy. LEVAQUIN dosage: unknown. Patient recovered.

LEVAQUIN problem was reported by a Pharmacist from UNITED STATES on Dec 06, 2005. Female patient was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. LEVAQUIN dosage: 500 MG, ORAL. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported LEVAQUIN problem on Dec 08, 2005. Female patient, 30 years of age, was treated with LEVAQUIN. After drug was administered, patient experienced the following problems/side effects: overdose. LEVAQUIN dosage: 750 MG, 4 IN 1 DAY, ORAL. Patient was hospitalized. Patient recovered.

Showing 1-75 of 866 Next >

Ask Our Patient Community about LEVAQUIN

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

Q
Quazepam
Quetiapine